Page last updated: 2024-10-27

fexofenadine and Ventricular Fibrillation

fexofenadine has been researched along with Ventricular Fibrillation in 1 studies

fexofenadine: a second generation antihistamine; metabolite of the antihistaminic drug terfenadine; structure in first source; RN refers to HCl
fexofenadine : A piperidine-based anti-histamine compound.

Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pinto, YM1
van Gelder, IC1
Heeringa, M1
Crijns, HJ1

Other Studies

1 other study available for fexofenadine and Ventricular Fibrillation

ArticleYear
QT lengthening and life-threatening arrhythmias associated with fexofenadine.
    Lancet (London, England), 1999, Mar-20, Volume: 353, Issue:9157

    Topics: Aged; Electrocardiography; Histamine H1 Antagonists; Humans; Long QT Syndrome; Male; Syncope; Tachyc

1999